ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

Relative Value

The Relative Value of one ATAI stock under the Base Case scenario is 2.07 USD. Compared to the current market price of 1.37 USD, ATAI Life Sciences NV is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATAI Relative Value
Base Case
2.07 USD
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
69
vs Industry
1
Median 3Y
946.8
Median 5Y
880.9
Industry
2.6
Forward
505.8
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.4
Industry
23
Forward
-1.7
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-4
Industry
17.8
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-4
Industry
25.4
vs History
74
vs Industry
58
Median 3Y
1.4
Median 5Y
1.5
Industry
2.2
vs History
46
vs Industry
1
Median 3Y
389.3
Median 5Y
310
Industry
2.8
Forward
352.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
57
Median 3Y
-1.5
Median 5Y
-1.5
Industry
13.7
Forward
-1.5
vs History
vs Industry
54
Median 3Y
-1.5
Median 5Y
-1.5
Industry
17.2
Forward
-1.5
vs History
vs Industry
55
Median 3Y
-2.1
Median 5Y
-2.3
Industry
16.5
vs History
vs Industry
41
Median 3Y
-2.1
Median 5Y
-2.3
Industry
19.3
vs History
79
vs Industry
56
Median 3Y
2.5
Median 5Y
3.3
Industry
2

Multiples Across Competitors

ATAI Competitors Multiples
ATAI Life Sciences NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
ATAI Life Sciences NV
NASDAQ:ATAI
229.8m USD 603.3 -4 -1.4 -1.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
DE
ATAI Life Sciences NV
NASDAQ:ATAI
Average P/E: 33.1
Negative Multiple: -4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top